Results 81 to 90 of about 2,032,293 (232)
Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disease for which there is currently no known cure. This systematic review explores the efficacy of genetic therapies used to target ALS in preclinical studies using in vivo rodent models. Outcomes investigated include the total number of motor neurons, rodent survival, and muscle function
Hannah E. Wedgwood +2 more
wiley +1 more source
The Ice, Cloud, and Land Elevation Satellite-2 (ICESat-2) provides an extraordinary opportunity to support global large-scale forest carbon mapping, but further research is needed in order to obtain wall-to-wall forest aboveground biomass (AGB) maps with
Juan Guerra-Hernández +8 more
doaj +1 more source
Chronic Non‐Progressive Neurophysiology in an ALS Patient Treated With Tofersen for 6 Years
Muscle &Nerve, Volume 74, Issue 6, Page 1668-1671, December 2026.
Ivar Winroth +6 more
wiley +1 more source
FMRP‐Mediated Proteasome Regulation: A Novel Mechanism in ALS Pathology
Schematic model of TDP‐43/TNKS‐mediated proteasome regulation in WT, FMRP‐depleted, and TDP‐43A315T‐Tg ALS neurons. In WT neurons, cytoplasmic TDP‐43 partially sequesters TNKS, maintaining balanced PI31 ribosylation and proteasome activity. FMRP depletion promotes nuclear translocation of TDP‐43, enhances TNKS/PI31 interaction, and increases axonal ...
Pritha Majumder +5 more
wiley +1 more source
ALS Focus Wave 1 - Insurance Needs and Financial Burdens Survey
This NeuroVERSE record contains two files: ALSFocus_Wave1_Public.csv – This data file contains responses from both the Demographics survey and the survey on Insurance Needs and Financial Burdens, which were fielded in Wave 1 of ALS Focus.
The ALS Association
core +1 more source
Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol [PDF]
Background: Amyotrophic lateral sclerosis (ALS) is a chronic neurodegenerative rare disease that affects motor neurons in the brain, brainstem, and spinal cord, resulting in progressive weakness and atrophy of voluntary skeletal muscles.
TUDCA-ALS Study Group +4 more
core
ABSTRACT Introduction/Aims Given limited research on patient perspectives of speech‐language pathology (SLP) services in ALS care, this study aimed to assess the satisfaction with, and understanding of, SLP services by people with ALS (pwALS) and to examine the alignment between services received and patient‐reported impairments.
Jennafer D. Best +3 more
wiley +1 more source
Chromosome 9 ALS and FTD locus is probably derived from a single founder. [PDF]
We and others have recently reported an association between amyotrophic lateral sclerosis (ALS) and single nucleotide polymorphisms on chromosome 9p21 in several populations.
Rollinson, PS +97 more
core +1 more source
Potential Diets to Improve Mitochondrial Activity in Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease, the pathogenesis of which is based on alternations in the mitochondria of motor neurons, causing their progressive death.
1000050242110 +12 more
core +1 more source
TDP-43 is linked to human diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD). Expression of TDP-43 in yeast is known to be toxic, cause cells to elongate, form liquid-like aggregates, and inhibit autophagy and ...
Sangeun Park +3 more
doaj +1 more source

